Affiliations 

  • 1 Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Jakarta, Indonesia
  • 2 Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
  • 3 Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia
  • 4 Department of Medicine, School of Medicine National Yang-Ming University, Taipei, Taiwan
  • 5 University of the East Ramon Magsaysay Memorial Medical Center Inc., Quezon City, Philippines
  • 6 Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan
  • 7 Department of Internal Medicine, University of Medicine and Pharmacy, Hue University, Hue City, Vietnam
  • 8 Division of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, Korea
  • 9 Faculty of Cardiology Service, Hanyang University Medical Center, Seoul, Korea
  • 10 Fatima Memorial Hospital, Lahore, Pakistan
  • 11 Section of Cardiology, Department of Medicine, Medical Center Manila, Manila, Philippines
  • 12 MIOT International Hospital, Chennai, India
  • 13 Cardiology Division, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
  • 14 Department of General Medicine, Tan Tock Seng Hospital, Singapore City, Singapore
  • 15 Division of Nephrology Department of Medicine, Yong Loo Lin School of Medicine, Singapore City, Singapore
  • 16 Faculty of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia
  • 17 Department of Physiology, King George's Medical University, Lucknow, India
  • 18 Department of Internal Medicine, National Taiwan University College of Medicine, Taipei City, Taiwan
  • 19 Divisions of Hypertension and Heart Failure, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
  • 20 Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, Shanghai Key Laboratory of Hypertension, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
J Clin Hypertens (Greenwich), 2020 03;22(3):423-430.
PMID: 31955506 DOI: 10.1111/jch.13753

Abstract

Cardiovascular Disease (CVD) is the leading cause of deaths worldwide, contributing to about 30% of all deaths. Half of the cases of CVD are estimated in Asia, the world's most populous continent. Hypertension, a major modifiable risk factor for CVD, results in more deaths than any other CV risk factors in the Asian regions. The total number of patients with hypertension is likely to grow as the population ages. The proportion of the elderly population aged 65 years or more in Asia is expected to increase from 7.4% in 2015 to 10.9% in 2030. It is important to note that more than half (54%) of the world's population live in Asia. Aside of being the biggest single risk factor for global deaths, hypertension is also an important precursor and most common risk factor of heart failure (HF). An increase in HF prevalence is clearly related to the rapid epidemiological transition caused by changes in lifestyle in Asian countries. However, the availability of data on HF burden and health care delivery is limited in Asia compared with Europe and North America. This reality has driven the working group of Asian experts for example the HOPE Asia Network to concentrate on hypertension as risk factors for CVD, with the mission to improve the management of hypertension resulting in organ protection toward a goal of achieving "ZERO" CV event in Asia. This paper aims to give an overview regarding the heart problems caused by hypertension in Asia, focus on HF.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.